Literature DB >> 26518648

Nanomedicine: Past, present and future - A global perspective.

Esther H Chang1, Joe B Harford2, Michael A W Eaton3, Patrick M Boisseau3, Admire Dube4, Rose Hayeshi4, Hulda Swai4, Dong Soo Lee5.   

Abstract

Nanomedicine is an emerging and rapidly evolving field and includes the use of nanoparticles for diagnosis and therapy of a variety of diseases, as well as in regenerative medicine. In this mini-review, leaders in the field from around the globe provide a personal perspective on the development of nanomedicine. The focus lies on the translation from research to development and the innovation supply chain, as well as the current status of nanomedicine in industry. The role of academic professional societies and the importance of government funding are discussed. Nanomedicine to combat infectious diseases of poverty is highlighted along with other pertinent examples of recent breakthroughs in nanomedicine. Taken together, this review provides a unique and global perspective on the emerging field of nanomedicine.
Copyright © 2015. Published by Elsevier Inc.

Keywords:  Diagnostics; Drug delivery; Funding; Imaging; Innovation; Nanomedicine

Mesh:

Year:  2015        PMID: 26518648     DOI: 10.1016/j.bbrc.2015.10.136

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  30 in total

1.  Where Do Epigenetics and Developmental Origins Take the Field of Developmental Psychopathology?

Authors:  Joel T Nigg
Journal:  J Abnorm Child Psychol       Date:  2016-04

2.  Self-assembly Stability Compromises the Efficacy of Tryptophan-Containing Designed Anti-measles Virus Peptides.

Authors:  Diogo A Mendonça; Tiago N Figueira; Manuel N Melo; Olivia Harder; Stefan Niewiesk; Anne Moscona; Matteo Porotto; Ana Salomé Veiga
Journal:  J Nanomed Nanotechnol       Date:  2019-03-12

Review 3.  Targeting Oxidative Stress Using Nanoparticles as a Theranostic Strategy for Cardiovascular Diseases.

Authors:  Kye S Kim; Chul Gyu Song; Peter M Kang
Journal:  Antioxid Redox Signal       Date:  2018-01-30       Impact factor: 8.401

4.  CFD Analysis and Life Cycle Assessment of Continuous Synthesis of Magnetite Nanoparticles Using 2D and 3D Micromixers.

Authors:  Sergio Leonardo Florez; Ana Lucia Campaña; M Juliana Noguera; Valentina Quezada; Olga P Fuentes; Juan C Cruz; Johann F Osma
Journal:  Micromachines (Basel)       Date:  2022-06-19       Impact factor: 3.523

Review 5.  Molecular imaging with nanoparticles: the dwarf actors revisited 10 years later.

Authors:  Gudrun C Thurner; Paul Debbage
Journal:  Histochem Cell Biol       Date:  2018-11-16       Impact factor: 4.304

6.  In vivo biodistribution, biocompatibility, and efficacy of sorafenib-loaded lipid-based nanosuspensions evaluated experimentally in cancer.

Authors:  Shaomei Yang; Bo Zhang; Xiaowei Gong; Tianqi Wang; Yongjun Liu; Na Zhang
Journal:  Int J Nanomedicine       Date:  2016-05-25

7.  Quantification of intracellular payload release from polymersome nanoparticles.

Authors:  Edoardo Scarpa; Joanne L Bailey; Agnieszka A Janeczek; Patrick S Stumpf; Alexander H Johnston; Richard O C Oreffo; Yin L Woo; Ying C Cheong; Nicholas D Evans; Tracey A Newman
Journal:  Sci Rep       Date:  2016-07-11       Impact factor: 4.379

Review 8.  Breaking Free of Control: How Conventional T Cells Overcome Regulatory T Cell Suppression.

Authors:  Emily R Mercadante; Ulrike M Lorenz
Journal:  Front Immunol       Date:  2016-05-18       Impact factor: 7.561

9.  Engineering Multi-Walled Carbon Nanotube Therapeutic Bionanofluids to Selectively Target Papillary Thyroid Cancer Cells.

Authors:  Idit Dotan; Philip J R Roche; Miltiadis Paliouras; Elliot J Mitmaker; Mark A Trifiro
Journal:  PLoS One       Date:  2016-02-22       Impact factor: 3.240

10.  Opportunities and obstacles to the development of nanopharmaceuticals for human use.

Authors:  Nasser Nassiri Koopaei; Mohammad Abdollahi
Journal:  Daru       Date:  2016-10-06       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.